Bonduelle S.C.A. (BON)
Euronext Paris · France · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 8.500 |
|---|---|
| 52-week range | 7.350 – 11.360 |
| Return, 1 month / 3 months | +6.1% / −0.9% |
| Return, 1 year / 3 years | −3.7% / −12.5% |
| Trend | Below its 200-day average |
| RSI (14) | 57 |
| Volatility (1 year) | 29.7% |
| Worst drawdown (1 year) | -34.1% |
| Average daily value traded | 0.12M EUR |
| Dividend yield | 2.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bonduelle is a French food company that prepares and markets vegetables for consumers and food-service customers. It offers canned, frozen and fresh-cut vegetables, along with prepared salads and vegetable-based ready meals, sold under its own brands and as retailer-brand products. The group grows and sources crops through partnerships with farmers and operates processing plants in several countries, with its home base in northern France. Its customers include supermarkets, restaurants, caterers and other food businesses across Europe and beyond.
On this site Bonduelle S.C.A. appears as a stock on the Euronext Paris (France), code BON, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bonduelle S.C.A. (BON) trades on the Euronext Paris in France. It last closed at EUR 8.500 on 23 October 2026.
Its price-based Market X-Ray is 59 out of 100 (a fair price profile), ranking 230 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 3.7% and over the last three months it fell 0.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 58 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -2.2% | ||
| From 52-week high | -23.8% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -0.9% | ||
| 6-month return | -0.8% | ||
| 12-month return, skipping the last month | -9.2% | ||
| Stability (higher is calmer) | 62 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 29.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -34.1% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.12M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 46 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.9% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | +6.1% |
| 3 months | −0.9% |
| 6 months | −0.8% |
| 1 year | −3.7% |
| 3 years | −12.5% |
| 5 years | −55.5% |
Signals
| 50-day / 200-day average | 8.327 / 8.687 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.262 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jan 2026 | EUR 0.2500 |
| 7 Jan 2025 | EUR 0.2000 |
| 2 Jan 2024 | EUR 0.2500 |
| 3 Jan 2023 | EUR 0.3000 |
| 3 Jan 2022 | EUR 0.4500 |
| 5 Jan 2021 | EUR 0.4000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.